Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Bivalent Killed Whole Cell Oral Cholera Vaccine in Kolkata
NCT00289224Phase 3Completed
- Sponsor
- International Vaccine Institute
- Start
- Jul 2006
- Primary completion
- Dec 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cholera comparing Cholera Vaccine with Placebo (2 arms). Primary endpoint: Culture-proven V. cholerae O1 diarrhoea episodes severe enough to require treatment in a health care facility at 1095 days. Started Jul 2006; status: completed.
02
Drugs
cholera vaccine (inactivated, oral)
03
Conditions
cholera
Beyond the preview
Go deeper on NCT00289224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289224.